BioSpace News Archive

Ocular Therapeutix™, Inc. announced that it will report fourth quarter and full year ended December 31, 2017 financial results on Thursday, March 8, 2018.

Veeva Systems, Inc. announced results for its fiscal fourth quarter and full year ended January 31, 2018.

Heron Therapeutics, Inc. reported financial results for the three and twelve months ended December 31, 2017 and highlighted recent corporate progress.

Acceleron Pharma Inc. provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2017.

Five Prime Therapeutics, Inc. provided a corporate update and reported financial results for the fourth quarter and full year ending December 31, 2017.

“We made tremendous progress across the spectrum of our Alzheimer’s and diabetes programs this past year, and look forward to continuing this momentum in 2018 as we anticipate reporting topline results in April from Part A of our Phase 3 STEADFAST study of azeliragon in patients with mild Alzheimer’s disease,” said Steve Holcombe, president and CEO of vTv Therapeutics.